Under the frame of the import substitution strategy, Bright Way Group is ready to implement contract manufacturing projects with foreign partners, resulting in local manufacturing content of drugs, which are important for the Russian patients, but used to be purchased abroad.
Bright Way Group is fully aware that the people's health and life quality depend on the company's quality and performance efficiency, therefore undertakes its activities on long-term, mutually beneficial, socially responsible and honest partnerships.
2021 commissioning
As part of its strategic directions Bright Way Group makes significant investments in the development of production facilities.
New production complex will be commissioned in 2021 (Moscow)
Modern high-tech production of various forms of full cycle production
Integrated quality management system in accordance with the requirements of GMP and ISO 9001:2015
A team of highly qualified specialists with vast experience
Own pilot industrial site
Chemical-analytical and microbiological laboratories
Warehouses that meet the requirements of modern logistics and GDP standards: own warehouse complex
> 13 000 pallets can reduce operating load by eliminating third-party logistics operators. The complex is ready to outsource the full range of logistics services
Proven procedure for the transfer of technology for the production of drugs
Experience in implementing projects in the pharmaceutical business in all areas of activity. Close and long-term cooperation with manufacturers of API.
Bright Way LLC as a member of the group of companies, has been listed among the TOP-3 of API importers in Russia for 20 years